Full video transcriptClick to expand
Auto-generated transcript of @myantiinflammatorylife's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00This is the biggest mistake that I see people make all of the time when they start their GLP1 journey
- 0:04is they continue to eat a lot of the things that they were eating before and then they get super frustrated
- 0:09because it's not working.
- 0:11The older we get, especially over the age of 35, them are insulin sensitive, we become.
- 0:15If you're insulin resistant, if you have PCOS, you are inflamed.
- 0:19You are going to struggle with losing weight while you're inflamed.
- 0:24So what's the fastest way to get rid of your inflammation?
- 0:27Number one, I want to scream as loud as possible from the rooftops to go gluten free.
- 0:31When you have PCOS or insulin resistance, you eat gluten, your body starts to attack the gluten, which then causes inflammation.
- 0:38When you have inflammation, you can't lose weight.
- 0:40Secondary to that, if you're inflamed, if you have insulin resistance, sugar is going to affect you a whole lot differently.
- 0:46It does someone without those things.
- 0:48Something as simple as oatmeal, if you do not pair it with protein and fiber, it is going to spike your sugar, make you hungrier,
- 0:56and keep you from losing weight.
- 0:58Most people who have insulin resistance in PCOS need a lower carbohydrate intake.
- 1:03Does that mean you go keto? No. Does that mean you go under 100 grams of carbs? No.
- 1:08Usually the magic number in my experience with my clients is somewhere around 120 to 150 grams of carbs a day
- 1:15and keep that in the morning and not at night.
- 1:19Then lastly, you guys got to move. Do you have to do 10,000 steps? No.
- 1:22Do you need to get out and walk every single day? Absolutely.
- 1:25Having 34,000 steps a day or having less than that?
- 1:28A lot of you guys have less than that because you're working from home.
- 1:31It doesn't help anything.
- 1:3330 minutes of walking, no matter how fast or slow, it lowers cortisol levels by 70%.
- 1:38Lowers insulin resistance and helps you stay in a calorie deficit.
GLP-1 not working? What the science says about non-response
Quick answer
GLP-1 receptor agonists show reduced efficacy when patients do not make concurrent dietary changes, which is consistent with clinical guidelines from the Obesity Society and FDA labeling for semaglutide and tirzepatide. Women with PCOS frequently present with hyperinsulinemia and may benefit from lower-glycemic dietary patterns, but this should be individualized based on labs and clinical assessment, not blanket gluten elimination. The claim that a 30-minute walk reduces cortisol by 70% is not supported by published clinical data and should not be repeated as fact.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GLP-1 not working? What the science says about non-response, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.
PubMed
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance
Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.
PubMed
Tirzepatide Once Weekly for the Treatment of Obesity
Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.
PubMed
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction
Used for continuation, stopping, and maintenance questions after initial weight loss.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GLP-1 not working? What the science says about non-response is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "GLP-1 not working? What the science says about non-response" from myantiinflammatorylife. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists show reduced efficacy when patients do not make concurrent dietary changes, which is consistent with clinical guidelines from the Obesity Society and FDA labeling for semaglutide and tirzepatide.
The reason this review is not generic is the source wording and the canonical claim label "glp1 glp1 not working 3 reasons why your glp 1 isn t working and." In this clip, the useful excerpt is: "This is the biggest mistake that I see people make all of the time when they start their GLP1 journey is they continue to eat a lot of the things that they were eating before and then they get super frustrated because it's not working." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
GLP-1 receptor agonists show reduced efficacy when patients do not make concurrent dietary changes, which is consistent with clinical guidelines from the Obesity Society and FDA labeling for semaglutide and tirzepatide.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- GLP-1 receptor agonists show reduced efficacy when patients do not make concurrent dietary changes, which is consistent with clinical guidelines from the Obesity Society and FDA labeling for semaglutide and tirzepatide. Women with PCOS frequently present with hyperinsulinemia and may benefit from lower-glycemic dietary patterns, but this should be individualized based on labs and clinical assessment, not blanket gluten elimination. The claim that a 30-minute walk reduces cortisol by 70% is not supported by published clinical data and should not be repeated as fact.
- The STEP 1 trial (Wilding et al., NEJM 2021) showed semaglutide plus lifestyle intervention produced greater weight loss than medication alone, supporting the idea that diet matters on GLP-1s.
- No published study supports a 70% cortisol reduction from a 30-minute walk. This figure is not cited and does not appear in peer-reviewed literature.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The STEP 1 trial (Wilding et al., NEJM 2021) showed semaglutide plus lifestyle intervention produced greater weight loss than medication alone, supporting the idea that diet matters on GLP-1s.
- No published study supports a 70% cortisol reduction from a 30-minute walk. This figure is not cited and does not appear in peer-reviewed literature.
- Gluten causes immune-mediated inflammation in people with celiac disease, which affects roughly 1% of the population. There is no strong evidence this applies to people with PCOS who have not been diagnosed with celiac disease or non-celiac gluten sensitivity.
- A 2012 randomized trial by Marsh et al. (American Journal of Clinical Nutrition) found low-glycemic diets improved insulin sensitivity and menstrual regularity in PCOS, lending partial support to lower-carbohydrate approaches.
- The claim that people with insulin resistance should eat under 150g of carbs per day is a reasonable clinical starting point for some patients, but it is not a universal threshold and should be individualized with a provider.
- Daily walking does modestly reduce cortisol and improve insulin sensitivity over time, but the benefits are cumulative and not as dramatic as a single-session 70% reduction figure suggests.
- If a GLP-1 medication appears to be underperforming, the appropriate response is a clinical review of titration, injection technique, and dietary patterns, not self-directed elimination diets based on social media content.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @myantiinflammatorylife actually say?
The creator argues that GLP-1 medications underperform when people keep eating the same foods, and offers three fixes: go gluten-free, cut carbs to 120-150g per day, and walk daily. The most specific claim is that "30 minutes of walking, no matter how fast or slow, it lowers cortisol levels by 70%." She also says gluten triggers immune attacks that cause inflammation, which then blocks weight loss in people with PCOS or insulin resistance. These are not throwaway comments. They are presented as clinical guidance for a large audience.
The creator does get credit for framing dietary change as part of GLP-1 success, which is consistent with how these medications are supposed to work. But several claims range from oversimplified to outright unsupported, and the cortisol figure in particular needs serious scrutiny.
Does the science back this up?
Some of it, partially. The relationship between low-carbohydrate eating and improved insulin sensitivity in PCOS is reasonably well-supported. The rest gets shakier fast.
On carbohydrate intake: a 2012 randomized trial by Marsh et al. in the American Journal of Clinical Nutrition found that a low-glycemic-index diet improved menstrual regularity and insulin sensitivity in women with PCOS compared to a standard healthy diet. A target of 120-150g of carbohydrates is not an unreasonable starting range for someone with insulin resistance, though it is not a universal prescription and the evidence does not produce a single "magic number."
On walking and cortisol: a 30-minute walk does appear to modestly reduce cortisol and perceived stress in some studies. Edwards et al. (2018, Neuroscience and Biobehavioral Reviews) reviewed exercise and stress-hormone responses and found benefits, but reductions of 70% from a single 30-minute walk are not supported in the peer-reviewed literature. That figure is not cited and does not appear to originate from a published study.
On gluten and PCOS: this is where the science largely falls apart. There is no strong clinical evidence that gluten triggers immune-mediated inflammation specifically in people with PCOS who do not have celiac disease or non-celiac gluten sensitivity.
What did they get wrong (or right)?
The gluten claim is the weakest part of this video. The creator says "your body starts to attack the gluten, which then causes inflammation" in people with PCOS. That is a description of celiac disease, an autoimmune condition affecting roughly 1% of the population. It does not apply broadly to people with PCOS or insulin resistance. Conflating immune reactivity to gluten with general PCOS inflammation is not supported by current evidence. A 2021 review by Esposito et al. in Nutrients found no consistent benefit of gluten-free diets in non-celiac individuals for metabolic outcomes.
The "70% cortisol" claim is a red flag. Specific percentage figures like this almost always trace back to a single small study, a misquote, or no study at all. No randomized controlled trial in the published literature supports a 70% cortisol reduction from a single 30-minute walk. Presenting it as fact to 88,000 viewers is irresponsible.
What she gets right: pairing carbohydrates with protein and fiber to blunt glucose spikes is legitimate advice. The general point that GLP-1 medications work better alongside dietary changes is consistent with prescribing guidelines. Recommending daily movement without fixating on step counts is reasonable and accessible.
What should you actually know?
GLP-1 receptor agonists like semaglutide and tirzepatide are not passive medications. Clinical trial data from the STEP and SURMOUNT programs consistently show that participants who made dietary and activity changes lost more weight than those who did not. So the creator's central premise, that diet matters on GLP-1s, is correct.
But dietary advice for PCOS and insulin resistance should come from a provider who has reviewed your labs, not a TikTok video. Going gluten-free without celiac disease or confirmed non-celiac gluten sensitivity is not evidence-based for weight loss and may make it harder to meet fiber and micronutrient targets. A carbohydrate target of 120-150g per day may work for some people with insulin resistance, but it is not a one-size-fits-all recommendation.
If your GLP-1 medication does not appear to be working, the right next step is a conversation with your prescriber about titration, injection technique, dietary patterns, and whether there are underlying conditions affecting your response. Not a gluten-free pantry overhaul based on a social media video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
myantiinflammatorylife · TikTok creator
88.5K views on this video
GLP1 not working? 3 reasons why your GLP-1 isn’t working and how to fix it #glp1 #glp1journey #glp1results #pcosweightloss #insulinresistance
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the step 1 trial (wilding et al., nejm 2021) showed?
The STEP 1 trial (Wilding et al., NEJM 2021) showed semaglutide plus lifestyle intervention produced greater weight loss than medication alone, supporting the idea that diet matters on GLP-1s.
What does the video say about no published study supports a 70% cortisol reduction from a?
No published study supports a 70% cortisol reduction from a 30-minute walk. This figure is not cited and does not appear in peer-reviewed literature.
What does the video say about gluten causes immune-mediated inflammation in people with celiac disease,?
Gluten causes immune-mediated inflammation in people with celiac disease, which affects roughly 1% of the population. There is no strong evidence this applies to people with PCOS who have not been diagnosed with celiac disease or non-celiac gluten sensitivity.
What does the video say about a 2012 randomized trial by marsh et al. (american journal?
A 2012 randomized trial by Marsh et al. (American Journal of Clinical Nutrition) found low-glycemic diets improved insulin sensitivity and menstrual regularity in PCOS, lending partial support to lower-carbohydrate approaches.
What does the video say about the claim?
The claim that people with insulin resistance should eat under 150g of carbs per day is a reasonable clinical starting point for some patients, but it is not a universal threshold and should be individualized with a provider.
What does the video say about daily walking does modestly reduce cortisol?
Daily walking does modestly reduce cortisol and improve insulin sensitivity over time, but the benefits are cumulative and not as dramatic as a single-session 70% reduction figure suggests.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by myantiinflammatorylife, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.